STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
Fluidx Medical Technology, Inc.
ViroMissile, Inc.
AstraZeneca
MacroGenics
Ocellaris Pharma, Inc.
iOmx Therapeutics AG
HiFiBiO Therapeutics
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Novelty Nobility, Inc.
Travera Inc
Kazia Therapeutics Limited
Numab Therapeutics AG
NextPoint Therapeutics, Inc.
GI Innovation, Inc.
Xencor, Inc.
Pfizer
DNAtrix, Inc.
Ipsen
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
Hoffmann-La Roche
Tempest Therapeutics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Nektar Therapeutics
MacroGenics
SpeciCare
Celgene
Mirror Biologics, Inc.
Shenzhen BinDeBio Ltd.
Pfizer
Daiichi Sankyo
Merck Sharp & Dohme LLC
Novartis
GE Healthcare
INSYS Therapeutics Inc
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)